Showing session: reset
CAR-T, TCR, and Beyond: A Rapidly Evolving Revolution in Cancer Cellular Immunotherapeutics
- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
CAR-T: A brief historical perspective
Joseph McGuirk
University of Kansas Medical Center, Westwood, KS, United States
- Free
- slides video
- audio + slides
- All slides included
CAR-T cells in the clinic: Strategies to enhance efficacy and reduce toxicity
Saad J Kenderian
Mayo Clinic, Rochester, MN, United States
- Free
- audio + slides
- Some slides withheld
Boutique to global regulatory approval: Constantly enhancing and improving engineered T cells
Bruce Levine
University Of Pennsylvania, Philadelphia, PA, United States
- Free
- Coming soon
- Some slides withheld
Lessons learned from comparing CD28 and 4-1BB-based CD19 CARs
Michel Sadelain
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
- Permission not
granted for presentation
The future of CAR T: Allogeneic approach
Ewelina Morawa
CRISPR Therapeutics, Cambridge, MA, United States